OncoBeta GmbH Press Releases

OncoBeta® GmbH has announced University Clinic of Rostock is participating in the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT) – for the treatment of non-melanoma skin cancer [NMSC]) treating its first...

OncoBeta® GmbH today announced Perth's Hollywood Private Hospital in Australia is the latest medical facility to participate in the global phase IV EPIC-Skin Study (Efficacy of Personalised Irradiation with Rhenium-SCT – for the treatment of...

An observational, multicentre, international, non-interventional programme to register patients diagnosed with non-melanoma skin cancer (NMSC), to monitor treatment outcomes and patterns of care at international hospitals